Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
BJU International
Published October 10, 2026
Comparative accuracy of imaging modalities for differentiating malignant small testicular masses.
October 10, 2026
Medspoke
Medspoke
Journal of Clinical Oncology (JCO)
Published October 9, 2026
00:00
--:--
Phase I/II Study of Bavdegalutamide, a Proteolysis-Targeting Chimera Androgen Receptor Degrader, ...
October 10, 2026
Share
Phase I/II Study of Bavdegalutamide, a Proteolysis-Targeting Chimera Androgen Receptor Degrader, in Metastatic Castration-Resistant Prostate Cancer.
https://www.medspoke.co/channel_journal?id=686&tap_id=15378
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
The Lancet Oncology
Published October 9, 2026
Invasive interval breast cancer rates after digital breast tomosynthesis plus synthesised mammogr...
October 10, 2026
Why are you reporting this TALK?
